Antimuscarinic Syndrome After Propofol Administration in the Emergency Department

Journal of Emergency Medicine

Volumn 33, Issue 1, 2007, Pages 29-32

  Snow, Karen A ^a   Clements, Elizabeth A ^a   Eppert, Alex J ^b   Judge, Bryan S ^b,c  

^a Pharmacy Department   (United States)

^b Emergency Medicine Grand Rapids Medical Education And Research Center   (United States)

^c HELEN DEVOS CHILDREN S HOSPITAL   (United States)

Author keywords

antimuscarinic syndrome; conscious sedation; physostigmine; propofol

Indexed keywords

ALCOHOL; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CANNABINOID; LORAZEPAM; MIDAZOLAM; NICOTINE; PETHIDINE; PHYSOSTIGMINE; PROMETHAZINE; PROPOFOL;

ADULT; AGITATION; ALCOHOL BLOOD LEVEL; ANTICHOLINERGIC EFFECT; ANTIMUSCARINIC SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONFUSION; CONSCIOUS SEDATION; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; ELBOW DISLOCATION; EMERGENCY WARD; FEMALE; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; SYMPTOM; URINALYSIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; EMERGENCY SERVICE, HOSPITAL; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PROPOFOL; RECEPTORS, MUSCARINIC; SYNDROME;

EID: 34447255139     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2007.02.045     Document Type: Article

References (33)

1. Burton J., Miner J., Shipley E., et al. Propofol for emergency department procedural sedation and analgesia: a tale of three centers. Acad Emerg Med 13 (2006) 24-30
2. Coll-Vinent B., Sala X., Fernandez C., et al. Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols. Ann Emerg Med 42 (2003) 767-772
3. Miner J.R., Martel M.L., Meyer M., Reardon R., and Biros M.H. Procedural sedation of critically ill patients in the emergency department. Acad Emerg Med 12 (2005) 124-128
4. Miner J.R., Biros M., Krieg S., et al. Randomized clinical trial of propofol versus methohexital for procedural sedation during fracture and dislocation reduction in the emergency department. Acad Emerg Med 10 (2003) 931-937
5. Albertson T.E., Walby W.F., and Joy R.M. Modification of GABA-mediated inhibition by various injectable anesthetics. Anesthesiology 77 (1992) 488-499
6. Mihic S.J. Acute effects of ethanol on GABAA and glycine receptor function. Neurochem Int 35 (1999) 115-123
7. Meuret P., Backman S.B., Bonhomme V., Plourde G., and Fiset P. Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers. Anesthesiology 93 (2000) 708-717
8. Fassoulaki A., Sarantopoulos C., and Derveniotis C. Physostigmine increases the dose of propofol required to induce anaesthesia. Can J Anaesth 44 (1997) 1148-1151
9. Kikuchi T., Wang Y., Sato K., and Okumura F. In vivo effects of propofol on acetylcholine release from the frontal cortex, hippocampus and striatum studied by intracerebral microdialysis in freely moving rats. Br J Anaesth 80 (1998) 644-648
10. Venkatesh K.H., and Chandramouli B.A. Postoperatvie hallucinations following propofol infusion in a neurosurgical patient: a diagnostic dilemma. J Neurosurg Anesthesiol 17 (2005) 176-177
11. Katsanoulas K., Papaioannou A., Fraidakis O., and Michaloudis D. Undiagnosed central anticholinergic syndrome may lead to dangerous complications. Eur J Anaesthesiol 16 (1999) 803-809
12. De Keulenaer B.L., Philpot S., Wilkinson M., Stephens D.P., and DeBacker A. Central anticholinergic syndrome in the intensive care unit. Eur J Anaesthesiol 21 (2004) 496-503
13. Brown D.V., Heller F., and Barkin R. Anticholinergic syndrome after anesthesia: a case report and review. Am J Ther 11 (2004) 144-153
14. Granacher R.P., Baldessarini R.J., and Messner E. Physostigmine treatment of delirium induced by anticholinergics. Am Fam Physician 13 (1976) 99-103
15. Burns M.J., Linden C.H., Graudins A., Brown R.M., and Fletcher K.E. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 35 (2000) 374-381
16. Schneck H.J., and Rupreht J. Central anticholinergic syndrome (CAS) in anesthesia and intensive care. Acta Anaesthesiol Belg 40 (1989) 219-228
17. Nietgen G.W., Honemann C.W., Chan C.K., Kamatchi G.L., and Durieux M.E. Volatile anaesthetics have differential effects on recombinant m1 and m3 muscarinic acetylcholine receptor function. Br J Anaesth 81 (1998) 569-577
18. Flood P., Ramirez-Latorre J., and Role L. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 86 (1997) 859-865
19. Hustveit O. Binding of fentanyl and pethidine to muscarinic receptors in rat brain. Jpn J Pharmacol 64 (1994) 57-59
20. Mortazavi S., Thompson J., Baghdoyan H.A., and Lydic R. Fentanyl and morphine, but not remifentanil, inhibit acetylcholine release in pontine regions modulating arousal. Anesthesiology 90 (1999) 1070-1077
21. Nagase Y., Kaibara M., Uezono Y., et al. Propofol inhibits muscarinic acetylcholine receptor-mediated signal transduction in Xenopus Oocytes expressing the rat M1 receptor. Jpn J Pharmacol 79 (1999) 319-325
22. Shyr M.H., Tsai T.H., Yang C.H., et al. Propofol anesthesia increases dopamine and serotonin activities at the somatosensory cortex in rats: a microdialysis study. Anesth Analg 84 (1997) 1344-1348
23. Anderson J.A. Reversal agents in sedation and anesthesia: a review. Anesth Prog 35 (1988) 43-47
24. Latta K.S., Ginsberg B., and Barkin R.L. Meperidine: a critical review. Am J Ther 9 (2002) 53-68
25. Baselt R. Disposition of toxic drugs and chemicals in man. 7th edn. (2004), Biomedical Publications, Foster City, CA
26. Simopoulos T.T., Smith H.S., Peeters-Asdourian C., and Stevens D.S. Use of meperidine in patient-controlled analgesia and the development of a normeperidine toxic reaction. Arch Surg 137 (2002) 84-88
27. Gutstein H., and Akil H. Opioid analgesics. In: Hardman J., and Limbird L. (Eds). Goodman and Gilman's pharmacological basis of therapeutics. 10th edn. (2001), McGraw-Hill, New York 569-620
28. Kurt T.L. Serum alcohol is not the same as blood alcohol concentration. Ann Emerg Med 25 (1995) 430-431
29. Erickson C., and Graham D. Alteration of cortical and reticular acetylcholine release by ethanol in vivo. J Pharmacol Exp Ther 185 (1973) 583-593
30. Garfield J., and Bukusoglu C. Propofol and ethanol produce additive hypnotic and anesthetic effects in the mouse. Anesth Analg 83 (1996) 156-161
31. Lauven P.M., and Stoeckel H. Flumazenil (Ro 15-1788) and physostigmine. Resuscitation 16 Suppl (1988) S41-S48
32. Tune L.E., Damlouji N.F., Holland A., et al. Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 2 (1981) 651-653
33. Martin B., and Howell P.R. Physostigmine: going ... going ... gone?. Two cases of central anticholinergic syndrome following anaesthesia and its treatment with physostigmine. Eur J Anaesthesiol 14 (1997) 467-470